 | | CAB | | Name: | 4,4-dihydroxy-5-oxo-L-norvaline | | Formula: | C5 H9 N O5 | | SMILES: | O=CC(O)(O)CC(C(=O)O)N | | InChi: | InChI=1S/C5H9NO5/c6-3(4(8)9)1-5(10,11)2-7/h2-3,10-11H,1,6H2,(H,8,9)/t3-/m0/s1 | | Definition date: | 1999-07-08 | | Last modified: | 2024-09-27 | | Identifier: | 4,4-dihydroxy-5-oxo-L-norvaline |
|
 | | CB9 | | Name: | (2R,4S)-2-[(1R)-1-{[(2S)-2-carboxy-2-phenylacetyl]amino}-2-oxoethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid | | Formula: | C17 H20 N2 O6 S | | SMILES: | O=C(NC(C=O)C1SC(C(N1)C(=O)O)(C)C)C(c2ccccc2)C(=O)O | | InChi: | InChI=1S/C17H20N2O6S/c1-17(2)12(16(24)25)19-14(26-17)10(8-20)18-13(21)11(15(22)23)9-6-4-3-5-7-9/h3-8,10-12,14,19H,1-2H3,(H,18,21)(H,22,23)(H,24,25)/t10-,11+,12+,14-/m1/s1 | | Synonyms: | Bound form of Carbenicillin | | Definition date: | 2010-10-12 | | Last modified: | 2024-09-27 | | Identifier: | (2R,4S)-2-[(1R)-1-{[(2S)-2-carboxy-2-phenylacetyl]amino}-2-oxoethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid |
|
 | | R1A | | Name: | 3-{[(2,2,5,5-TETRAMETHYL-1-OXO-2,5-DIHYDRO-1H-PYRROLIUM-3-YL)METHYL]DISULFANYL}-D-ALANINE | | Formula: | C12 H21 N2 O3 S2 | | SMILES: | O=C(O)C(N)CSSCC1=CC([N+](=O)C1(C)C)(C)C | | InChi: | InChI=1S/C12H20N2O3S2/c1-11(2)5-8(12(3,4)14(11)17)6-18-19-7-9(13)10(15)16/h5,9H,6-7,13H2,1-4H3/p+1/t9-/m0/s1 | | Synonyms: | S-(THIOMETHYL-3-[2,2,5,5-TETRAMETHYL PYRROLINE-1-OXYL]) CYSTEINE | | Definition date: | 2005-06-03 | | Last modified: | 2024-09-27 | | Identifier: | 3-{[(2,2,5,5-tetramethyl-1-oxo-2,5-dihydro-1H-pyrrolium-3-yl)methyl]disulfanyl}-L-alanine |
|
 | | R28 | | Name: | propan-2-yl 2-[[4-[2-(dimethylamino)ethyl-methyl-amino]-2-methoxy-5-(propanoylamino)phenyl]amino]-4-(1-methylindol-3-yl)pyrimidine-5-carboxylate | | Formula: | C32 H41 N7 O4 | | SMILES: | CCC(=O)Nc1cc(Nc2ncc(C(=O)OC(C)C)c(n2)c3cn(C)c4ccccc34)c(OC)cc1N(C)CCN(C)C | | InChi: | InChI=1S/C32H41N7O4/c1-9-29(40)34-24-16-25(28(42-8)17-27(24)38(6)15-14-37(4)5)35-32-33-18-22(31(41)43-20(2)3)30(36-32)23-19-39(7)26-13-11-10-12-21(23)26/h10-13,16-20H,9,14-15H2,1-8H3,(H,34,40)(H,33,35,36) | | Synonyms: | Mobocertinib, bound form | | Definition date: | 2020-08-26 | | Last modified: | 2024-09-27 | | Release date: | 2022-02-23 | | Identifier: | propan-2-yl 2-[[4-[2-(dimethylamino)ethyl-methyl-amino]-2-methoxy-5-(propanoylamino)phenyl]amino]-4-(1-methylindol-3-yl)pyrimidine-5-carboxylate |
|
 | | R2E | | Name: | 1-[4-[4-[[3,4-bis(chloranyl)-2-fluoranyl-phenyl]amino]-7-methoxy-quinazolin-6-yl]oxypiperidin-1-yl]propan-1-one | | Formula: | C23 H23 Cl2 F N4 O3 | | SMILES: | CCC(=O)N1CCC(CC1)Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC | | InChi: | InChI=1S/C23H23Cl2FN4O3/c1-3-20(31)30-8-6-13(7-9-30)33-19-10-14-17(11-18(19)32-2)27-12-28-23(14)29-16-5-4-15(24)21(25)22(16)26/h4-5,10-13H,3,6-9H2,1-2H3,(H,27,28,29) | | Synonyms: | Poziotinib, bound form | | Definition date: | 2020-08-26 | | Last modified: | 2024-09-27 | | Release date: | 2022-02-23 | | Identifier: | 1-[4-[4-[[3,4-bis(chloranyl)-2-fluoranyl-phenyl]amino]-7-methoxy-quinazolin-6-yl]oxypiperidin-1-yl]propan-1-one |
|
 | | CEM | | Name: | N-(1-CARBOXY-2-HYDROXY-4-OXO-BUTYL)-N-(3-OXO-CISPROPENYL)AMINE | | Formula: | C8 H11 N O5 | | SMILES: | O=CCC(O)C(NC=C/C=O)C(=O)O | | InChi: | InChI=1S/C8H11NO5/c10-4-1-3-9-7(8(13)14)6(12)2-5-11/h1,3-7,9,12H,2H2,(H,13,14)/b3-1-/t6-,7+/m0/s1 | | Definition date: | 1999-07-08 | | Last modified: | 2024-09-27 | | Identifier: | (3S)-3-hydroxy-5-oxo-N-[(1Z)-3-oxoprop-1-en-1-yl]-D-norvaline |
|
 | | R50 | | Name: | 2-methyl-1-[(4P)-3-methyl-4-(2-methyl-1,2,3,4-tetrahydroisoquinolin-6-yl)-1H-pyrrolo[2,3-c]pyridin-1-yl]prop-2-en-1-one, bound form | | Formula: | C22 H25 N3 O | | SMILES: | CC(C)C(=O)n1cc(C)c2c1cncc2c1ccc2CN(C)CCc2c1 | | InChi: | InChI=1S/C22H25N3O/c1-14(2)22(26)25-12-15(3)21-19(10-23-11-20(21)25)17-5-6-18-13-24(4)8-7-16(18)9-17/h5-6,9-12,14H,7-8,13H2,1-4H3 | | Definition date: | 2022-06-16 | | Last modified: | 2024-09-27 | | Release date: | 2022-10-12 | | Identifier: | 2-methyl-1-[(4P)-3-methyl-4-(2-methyl-1,2,3,4-tetrahydroisoquinolin-6-yl)-1H-pyrrolo[2,3-c]pyridin-1-yl]propan-1-one |
|
 | | R7U | | Name: | RUTHENIUM WIRE, 7 CARBON LINKER | | Formula: | C47 H65 N7 O Ru | | SMILES: | O(c1cccc(N(C)C)c1)CCCCCCCC4=C3C=CC2=CC=CN8C2=C3N(C=C4)[Ru]86%11(N7C(C5N6CCCC5)CCCC7)N9CCC=CC9C%10N%11CCCC%10 | | InChi: | InChI=1S/C27H31N3O.C10H18N2.C10H16N2.Ru/c1-30(2)23-12-8-13-24(20-23)31-19-7-5-3-4-6-10-21-16-18-29-27-25(21)15-14-22-11-9-17-28-26(22)27 | | Synonyms: | BIS[1H,1'H-2,2'-BIPYRIDINATO(2-)-KAPPA~2~N~1~,N~1'~][3-{[7-(1,10-DIHYDRO-1,10-PHENANTHROLIN-4-YL-KAPPA~2~N~1~,N~10~)HEP
TYL]OXY}-N,N-DIMETHYLANILINATO(2-)]RUTHENIUM | | Definition date: | 2006-02-24 | | Last modified: | 2024-09-27 | | Identifier: | [(2R,2'R)-2,2'-bipiperidinato(2-)-kappa~2~N~1~,N~1'~][3-{[7-(1,10-dihydro-1,10-phenanthrolin-4-yl-kappa~2~N~1~,N~10~)heptyl]oxy}-N,N-dimethylanilinato(2-)][(6R)-6-[(2S)-piperidin-2-yl-kappaN]-1,2,3,6-tetrahydropyridinato(2-)-kappaN]ruthenium |
|
 | | CIR | | Name: | CITRULLINE | | Formula: | C6 H13 N3 O3 | | SMILES: | O=C(O)C(N)CCCNC(=O)N | | InChi: | InChI=1S/C6H13N3O3/c7-4(5(10)11)2-1-3-9-6(8)12/h4H,1-3,7H2,(H,10,11)(H3,8,9,12)/t4-/m0/s1 | | Definition date: | 1999-07-08 | | Last modified: | 2024-09-27 | | Identifier: | N~5~-carbamoyl-L-ornithine |
|
 | | RBS | | Name: | N-(4-PHENYLAMINO-QUINAZOLIN-6-YL)-ACRYLAMIDE | | Formula: | C17 H14 N4 O | | SMILES: | O=C(/C=C)Nc3cc1c(ncnc1Nc2ccccc2)cc3 | | InChi: | InChI=1S/C17H14N4O/c1-2-16(22)20-13-8-9-15-14(10-13)17(19-11-18-15)21-12-6-4-3-5-7-12/h2-11H,1H2,(H,20,22)(H,18,19,21) | | Definition date: | 2006-08-02 | | Last modified: | 2024-09-27 | | Identifier: | N-[4-(phenylamino)quinazolin-6-yl]prop-2-enamide |
|
 | | 3GE | | Name: | N-[(1E)-2-formyl-3-hydroxyprop-1-en-1-yl]-3-[(S)-sulfino]-D-valine | | Formula: | C9 H15 N O6 S | | SMILES: | O=S(O)C(C)(C)C(NC=C(/CO)C=O)C(=O)O | | InChi: | InChI=1S/C9H15NO6S/c1-9(2,17(15)16)7(8(13)14)10-3-6(4-11)5-12/h3-4,7,10,12H,5H2,1-2H3,(H,13,14)(H,15,16)/b6-3-/t7-/m0/s1 | | Definition date: | 2014-08-15 | | Last modified: | 2024-09-27 | | Release date: | 2015-01-21 | | Identifier: | N-[(1E)-2-formyl-3-hydroxyprop-1-en-1-yl]-3-[(S)-sulfino]-D-valine |
|
 | | RGP | | Name: | GAMMA-GLUTAMYL PHOSPHATE | | Formula: | C5 H10 N O7 P | | SMILES: | O=C(OP(=O)(O)O)CCC(C(=O)O)N | | InChi: | InChI=1S/C5H10NO7P/c6-3(5(8)9)1-2-4(7)13-14(10,11)12/h3H,1-2,6H2,(H,8,9)(H2,10,11,12)/t3-/m1/s1 | | Synonyms: | 5-OXO-5-(PHOSPHONOOXY)-D-NORVALINE | | Definition date: | 2005-07-20 | | Last modified: | 2024-09-27 | | Identifier: | 5-oxo-5-(phosphonooxy)-D-norvaline |
|
 | | 3PX | | Name: | (3S)-3-(propan-2-yloxy)-L-proline | | Formula: | C8 H15 N O3 | | SMILES: | O=C(O)C1NCCC1OC(C)C | | InChi: | InChI=1S/C8H15NO3/c1-5(2)12-6-3-4-9-7(6)8(10)11/h5-7,9H,3-4H2,1-2H3,(H,10,11)/t6-,7-/m0/s1 | | Definition date: | 2011-04-26 | | Last modified: | 2024-09-27 | | Identifier: | (3S)-3-(propan-2-yloxy)-L-proline |
|
 | | RNX | | Name: | 1-(4-{[2-(4-{(4P)-4-[2-amino-4-(difluoromethyl)pyrimidin-5-yl]-6-[(3S)-3-methylmorpholin-4-yl]-1,3,5-triazin-2-yl}piperazin-1-yl)-2-oxoethoxy]methyl}piperidin-1-yl)prop-2-en-1-one | | Formula: | C28 H38 F2 N10 O4 | | SMILES: | C=CC(=O)N1CCC(CC1)COCC(=O)N1CCN(CC1)c1nc(nc(n1)c1cnc(N)nc1C(F)F)N1CCOCC1C | | InChi: | InChI=1S/C28H38F2N10O4/c1-3-21(41)37-6-4-19(5-7-37)16-44-17-22(42)38-8-10-39(11-9-38)27-34-25(20-14-32-26(31)33-23(20)24(29)30)35-28(36-27)40-12-13-43-15-18(40)2/h3,14,18-19,24H,1,4-13,15-17H2,2H3,(H2,31,32,33)/t18-/m0/s1 | | Definition date: | 2023-08-22 | | Last modified: | 2024-09-27 | | Release date: | 2024-08-28 | | Identifier: | 1-(4-{[2-(4-{(4P)-4-[2-amino-4-(difluoromethyl)pyrimidin-5-yl]-6-[(3S)-3-methylmorpholin-4-yl]-1,3,5-triazin-2-yl}piperazin-1-yl)-2-oxoethoxy]methyl}piperidin-1-yl)prop-2-en-1-one |
|
 | | RU8 | | Name: | bis(2,2'-bipyridine-kappa~2~N~1~,N~1'~)[2-iodo-N-(1,10-phenanthrolin-5-yl-kappa~2~N~1~,N~10~)acetamide]ruthenium(2+) | | Formula: | C34 H26 I N7 O Ru | | SMILES: | ICC(=O)Nc1cc7c6c2c1cccn2[Ru+2]%105(n3ccccc3c4ccccn45)(n6ccc7)n8ccccc8c9ccccn9%10 | | InChi: | InChI=1S/C14H10IN3O.2C10H8N2.Ru/c15-8-12(19)18-11-7-9-3-1-5-16-13(9)14-10(11)4-2-6-17-14 | | Definition date: | 2010-07-20 | | Last modified: | 2024-09-27 | | Identifier: | bis(2,2'-bipyridine-kappa~2~N~1~,N~1'~)[2-iodo-N-(1,10-phenanthrolin-5-yl-kappa~2~N~1~,N~10~)acetamide]ruthenium(2+) |
|
 | | CR0 | | Name: | [2-(1-AMINO-2-HYDROXYPROPYL)-2-HYDROXY-4-ISOBUTYL-5-OXO-2,5-DIHYDRO-1H-IMIDAZOL-1-YL]ACETALDEHYDE | | Formula: | C12 H21 N3 O5 | | SMILES: | O=CCN1C(=O)C(=NC1(O)C(N)C(O)C)CC(C)C | | InChi: | InChI=1S/C12H21N3O5/c1-6(2)4-8-11(19)15(5-9(17)18)12(20,14-8)10(13)7(3)16/h6-7,10,16,20H,4-5,13H2,1-3H3,(H,17,18)/t7-,10+,12-/m1/s1 | | Synonyms: | 1-(2-ETHANONE)-2-HYDROXY-2-(1-AMINO-2-METHYL-2-ETHANOL)-4-(2-DIMETHYL)ETHANE-IMIDAZOLINE-5-ONE | | Definition date: | 2004-02-05 | | Last modified: | 2024-09-27 | | Identifier: | [(2R)-2-[(1S,2R)-1-amino-2-hydroxypropyl]-2-hydroxy-4-(2-methylpropyl)-5-oxo-2,5-dihydro-1H-imidazol-1-yl]acetaldehyde |
|
 | | CRL | | Name: | N-{(1R)-2-[(4-CYANO-1,1-DIOXIDOTETRAHYDRO-2H-THIOPYRAN-4-YL)AMINO]-2-OXO-1-[(TRIMETHYLSILYL)METHYL]ETHYL}MORPHOLINE-4-CARBOXAMIDE | | Formula: | C17 H30 N4 O5 S Si | | SMILES: | O=S2(=O)CCC(C#N)(NC(=O)C(NC(=O)N1CCOCC1)C[Si](C)(C)C)CC2 | | InChi: | InChI=1S/C17H30N4O5SSi/c1-28(2,3)12-14(19-16(23)21-6-8-26-9-7-21)15(22)20-17(13-18)4-10-27(24,25)11-5-17/h14H,4-12H2,1-3H3,(H,19,23)(H,20,22)/t14-/m0/s1 | | Definition date: | 2006-01-31 | | Last modified: | 2024-09-27 | | Identifier: | N-{(1R)-2-[(4-cyano-1,1-dioxidotetrahydro-2H-thiopyran-4-yl)amino]-2-oxo-1-[(trimethylsilyl)methyl]ethyl}morpholine-4-carboxamide |
|
 | | CS1 | | Name: | S-(2-ANILINYL-SULFANYL)-CYSTEINE | | Formula: | C9 H12 N2 O2 S2 | | SMILES: | O=C(O)C(N)CSSc1ccccc1N | | InChi: | InChI=1S/C9H12N2O2S2/c10-6-3-1-2-4-8(6)15-14-5-7(11)9(12)13/h1-4,7H,5,10-11H2,(H,12,13)/t7-/m0/s1 | | Synonyms: | 3-[(2-AMINOPHENYL)DITHIO]-L-ALANINE | | Definition date: | 2007-02-02 | | Last modified: | 2024-09-27 | | Identifier: | 3-[(2-aminophenyl)disulfanyl]-L-alanine |
|
 | | CVE | | Name: | (3~{S})-3-[[(2~{R})-2-[3-methyl-2,6-bis(oxidanylidene)-5-[[4-(quinoxalin-2-ylamino)phenyl]carbonylamino]pyrimidin-1-yl]propanoyl]amino]-4-oxidanyl-butanoic acid | | Formula: | C27 H27 N7 O7 | | SMILES: | C[CH](N1C(=O)N(C)C=C(NC(=O)c2ccc(Nc3cnc4ccccc4n3)cc2)C1=O)C(=O)N[CH](CO)CC(O)=O | | InChi: | InChI=1S/C27H27N7O7/c1-15(24(38)30-18(14-35)11-23(36)37)34-26(40)21(13-33(2)27(34)41)32-25(39)16-7-9-17(10-8-16)29-22-12-28-19-5-3-4-6-20(19)31-22/h3-10,12-13,15,18,35H,11,14H2,1-2H3,(H,29,31)(H,30,38)(H,32,39)(H,36,37)/t15-,18+/m1/s1 | | Definition date: | 2017-12-07 | | Last modified: | 2024-09-27 | | Release date: | 2018-05-02 | | Identifier: | (3~{S})-3-[[(2~{R})-2-[3-methyl-2,6-bis(oxidanylidene)-5-[[4-(quinoxalin-2-ylamino)phenyl]carbonylamino]pyrimidin-1-yl]propanoyl]amino]-4-oxidanyl-butanoic acid |
|
 | | CWV | | Name: | [3-(1-aminoisoquinolin-6-yl)phenyl]boronic acid | | Formula: | C15 H13 B N2 O2 | | SMILES: | B(O)(O)c3cccc(c2cc1ccnc(N)c1cc2)c3 | | InChi: | InChI=1S/C15H13BN2O2/c17-15-14-5-4-11(8-12(14)6-7-18-15)10-2-1-3-13(9-10)16(19)20/h1-9,19-20H,(H2,17,18) | | Definition date: | 2017-10-05 | | Last modified: | 2024-09-27 | | Release date: | 2018-03-21 | | Identifier: | [3-(1-aminoisoquinolin-6-yl)phenyl]boronic acid |
|
 | | CXU | | Name: | CLOXACILLIN (OPEN FORM) | | Formula: | C19 H20 Cl N3 O5 S | | SMILES: | O=C(NC(C=O)C1SC(C(N1)C(=O)O)(C)C)c3c(onc3c2ccccc2Cl)C | | InChi: | InChI=1S/C19H20ClN3O5S/c1-9-13(14(23-28-9)10-6-4-5-7-11(10)20)16(25)21-12(8-24)17-22-15(18(26)27)19(2,3)29-17/h4-8,12,15,17,22H,1-3H3,(H,21,25)(H,26,27)/t12-,15+,17-/m1/s1 | | Synonyms: | (2R,4S)-2-[(1R)-1-({[3-(2-chlorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-2-oxoethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid | | Definition date: | 2011-08-16 | | Last modified: | 2024-09-27 | | Identifier: | (2R,4S)-2-[(1R)-1-({[3-(2-chlorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-2-oxoethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid |
|
 | | CXV | | Name: | (2R,4S)-2-[(1S)-1-({[3-(2-chlorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-2-oxoethyl]-5,5-dimethyl-1,3-thiazolid
ine-4-carboxylic acid | | Formula: | C19 H20 Cl N3 O5 S | | SMILES: | O=C(NC(C=O)C1SC(C(N1)C(=O)O)(C)C)c3c(onc3c2ccccc2Cl)C | | InChi: | InChI=1S/C19H20ClN3O5S/c1-9-13(14(23-28-9)10-6-4-5-7-11(10)20)16(25)21-12(8-24)17-22-15(18(26)27)19(2,3)29-17/h4-8,12,15,17,22H,1-3H3,(H,21,25)(H,26,27)/t12-,15-,17+/m0/s1 | | Synonyms: | CLOXACILLIN open form (1R form) | | Definition date: | 2011-08-17 | | Last modified: | 2024-09-27 | | Identifier: | (2R,4S)-2-[(1S)-1-({[3-(2-chlorophenyl)-5-methyl-1,2-oxazol-4-yl]carbonyl}amino)-2-oxoethyl]-5,5-dimethyl-1,3-thiazolidine-4-carboxylic acid |
|
 | | 6OY | | Name: | ethyl (4R)-4-[[(2S,4S)-1-[(2S)-3-methyl-2-[(5-methyl-1,2-oxazol-3-yl)carbonylamino]butanoyl]-4-phenyl-pyrrolidin-2-yl]carbonylamino]-5-[(3S)-2-oxidanylidenepyrrolidin-3-yl]pentanoate | | Formula: | C32 H43 N5 O7 | | SMILES: | CCOC(=O)CCC(NC(=O)C1N(CC(C1)c2ccccc2)C(=O)C(NC(=O)c3noc(c3)C)C(C)C)CC4CCNC4=O | | InChi: | InChI=1S/C32H43N5O7/c1-5-43-27(38)12-11-24(16-22-13-14-33-29(22)39)34-31(41)26-17-23(21-9-7-6-8-10-21)18-37(26)32(42)28(19(2)3)35-30(40)25-15-20(4)44-36-25/h6-10,15,19,22-24,26,28H,5,11-14,16-18H2,1-4H3,(H,33,39)(H,34,41)(H,35,40)/t22-,23+,24+,26-,28-/m0/s1 | | Definition date: | 2016-02-25 | | Last modified: | 2024-09-27 | | Release date: | 2016-06-22 | | Identifier: | N-(5-methyl-1,2-oxazole-3-carbonyl)-L-valyl-(4S)-N-{(2R)-5-ethoxy-5-oxo-1-[(3S)-2-oxopyrrolidin-3-yl]pentan-2-yl}-4-phenyl-L-prolinamide |
|
 | | 6P6 | | Name: | 1-(4-phenylazanylquinazolin-7-yl)ethanone | | Formula: | C16 H13 N3 O | | SMILES: | CC(=O)c1ccc2c(Nc3ccccc3)ncnc2c1 | | InChi: | InChI=1S/C16H13N3O/c1-11(20)12-7-8-14-15(9-12)17-10-18-16(14)19-13-5-3-2-4-6-13/h2-10H,1H3,(H,17,18,19) | | Definition date: | 2016-05-31 | | Last modified: | 2024-09-27 | | Release date: | 2016-08-10 | | Identifier: | 1-(4-phenylazanylquinazolin-7-yl)ethanone |
|
 | | 6P8 | | Name: | ~{N}-(4-phenylazanylquinazolin-7-yl)ethanamide | | Formula: | C16 H14 N4 O | | SMILES: | CC(=O)Nc1ccc2c(Nc3ccccc3)ncnc2c1 | | InChi: | InChI=1S/C16H14N4O/c1-11(21)19-13-7-8-14-15(9-13)17-10-18-16(14)20-12-5-3-2-4-6-12/h2-10H,1H3,(H,19,21)(H,17,18,20) | | Definition date: | 2016-05-31 | | Last modified: | 2024-09-27 | | Release date: | 2016-08-10 | | Identifier: | ~{N}-(4-phenylazanylquinazolin-7-yl)ethanamide |
|
